Physician profile
Ronald Millman
NPI 1508825852
$2,768.32
in general payments reported to CMS, 2019-2025
13 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,199 · 2020: $124 · 2021: $433 · 2022: $185 · 2023: $290 · 2024: $112 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,244.16 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Biofinity Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $348.45 | 2019-2021 | |
| Alcon Vision LLC | $240.98 | 2019-2023 | Total30 |
| Tarsus Pharmaceuticals, INC. | $168.27 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $153.82 | 2024-2025 | Infuse, Biotrue One Day |
| Allergan, INC. | $129.95 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $122.44 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $114.43 | 2019-2020 | |
| Glaukos Corporation | $92.02 | 2019 | |
| Dompe US, INC. | $59.99 | 2023 | Oxervate |
| New World Medical,INC. | $44.06 | 2019 | |
| Visioneering Technologies, INC. | $30.70 | 2019 | |
| Optos, INC. | $19.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Millman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.